Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 106151-106200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03992417
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
N/AActive, not recruiting
955 participants
Started: Jun 11, 2019 · Completed: Mar 31, 2027
1 condition2 sponsors114 locations
NCT03742245
Olaparib in Combination with Vorinostat in Patients with Relapsed/Refractory And/or Metastatic Breast Cancer
PHASE1Recruiting
28 participants
Started: Jun 11, 2019 · Completed: Mar 1, 2026
2 conditions3 sponsors1 location
NCT03985176
Delayed Cerebral Ischaemia and Coagulation Alterations After Aneurysmal Subarachnoid Haemorrhage
N/AActive, not recruiting
62 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03973372
ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement
N/AActive, not recruiting
852 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2027
2 conditions16 sponsors14 locations
NCT03978767
Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial
PHASE2Recruiting
286 participants
Started: Jun 10, 2019 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT03735667
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
NAActive, not recruiting
1,948 participants
Started: Jun 10, 2019 · Completed: Sep 30, 2034
1 condition1 sponsor75 locations
NCT03294460
Nicotinic Receptor Genetic Variation and Alcohol Reward
PHASE1Recruiting
128 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03975907
Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)
PHASE1/PHASE2Active, not recruiting
121 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition14 sponsors23 locations
NCT03741101
Treatment of NF1-related Plexiform Neurofibroma With Trametinib
PHASE2Active, not recruiting
15 participants
Started: Jun 10, 2019 · Completed: Dec 15, 2024
3 conditions2 sponsors1 location
NCT03968614
Electrical DN as an Adjunct to Eccentric Exercise, Stretching + MT for Achilles Tendinopathy
NARecruiting
110 participants
Started: Jun 10, 2019 · Completed: May 1, 2026
1 condition2 sponsors1 location
NCT03911557
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
PHASE2Active, not recruiting
14 participants
Started: Jun 8, 2019 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT03948490
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
NARecruiting
97 participants
Started: Jun 7, 2019 · Completed: Mar 31, 2026
1 condition3 sponsors1 location
NCT03839342
Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
PHASE2Active, not recruiting
26 participants
Started: Jun 7, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03627988
Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.
PHASE2Active, not recruiting
65 participants
Started: Jun 7, 2019 · Completed: May 31, 2026
1 condition1 sponsor2 locations
NCT03745339
Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder
N/ARecruiting
150 participants
Started: Jun 7, 2019 · Completed: Oct 1, 2026
2 conditions1 sponsor1 location
NCT03793166
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
PHASE3Active, not recruiting
1,175 participants
Started: Jun 7, 2019 · Completed: Sep 15, 2026
9 conditions1 sponsor864 locations
NCT03943173
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
EARLY_PHASE1Active, not recruiting
15 participants
Started: Jun 7, 2019 · Completed: Dec 27, 2025
31 conditions2 sponsors1 location
NCT03965325
FOcUs on Colorectal CAncer oUtcomes: Long-Term Study
N/AActive, not recruiting
133 participants
Started: Jun 7, 2019 · Completed: Jun 6, 2025
1 condition1 sponsor1 location
NCT04040530
Patient Reported Outcome After Nephron Sparing Treatment of Small Renal Tumours
N/AActive, not recruiting
187 participants
Started: Jun 7, 2019 · Completed: Feb 7, 2026
2 conditions3 sponsors2 locations
NCT03564561
Natural History of Pompe Disease
N/ARecruiting
20 participants
Started: Jun 7, 2019 · Completed: Mar 31, 2033
1 condition1 sponsor1 location
NCT04088292
Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
PHASE3Active, not recruiting
210 participants
Started: Jun 6, 2019 · Completed: Nov 30, 2024
1 condition5 sponsors4 locations
NCT03779711
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
PHASE2Active, not recruiting
95 participants
Started: Jun 6, 2019 · Completed: Feb 28, 2026
1 condition9 sponsors8 locations
NCT03817502
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
PHASE3Recruiting
330 participants
Started: Jun 6, 2019 · Completed: Dec 15, 2026
1 condition1 sponsor57 locations
NCT04183699
Optimizing the Number of Systematic COres During a MRI Target Biopsy
NARecruiting
265 participants
Started: Jun 6, 2019 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05678530
Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
N/ARecruiting
400 participants
Started: Jun 6, 2019 · Completed: Mar 31, 2026
1 condition1 sponsor15 locations
NCT03957252
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
N/AActive, not recruiting
2,800 participants
Started: Jun 6, 2019 · Completed: Mar 31, 2027
1 condition9 sponsors3 locations
NCT03819101
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
PHASE3Recruiting
1,210 participants
Started: Jun 6, 2019 · Completed: Mar 31, 2042
1 condition2 sponsors23 locations
NCT03625752
Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain
NAActive, not recruiting
60 participants
Started: Jun 6, 2019 · Completed: May 7, 2026
2 conditions2 sponsors2 locations
NCT04302220
Myopic Optic Neuropathy in Chinese High Myopia Population
N/AActive, not recruiting
813 participants
Started: Jun 6, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT03923270
Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer
PHASE1Active, not recruiting
25 participants
Started: Jun 6, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04115761
Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
PHASE2Recruiting
24 participants
Started: Jun 6, 2019 · Completed: Dec 30, 2026
1 condition1 sponsor3 locations
NCT04870866
NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
PHASE2Active, not recruiting
13 participants
Started: Jun 5, 2019 · Completed: Jun 16, 2027
1 condition9 sponsors2 locations
NCT03979235
Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation
N/ARecruiting
40 participants
Started: Jun 5, 2019 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT03959215
Back in the Game: a Smartphone Application to Support Athletes Returning to Sport After Serious Injury
NAActive, not recruiting
169 participants
Started: Jun 5, 2019 · Completed: Jul 31, 2024
1 condition6 sponsors7 locations
NCT03875781
Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer
PHASE3Recruiting
540 participants
Started: Jun 5, 2019 · Completed: Dec 5, 2026
2 conditions1 sponsor1 location
NCT03598309
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
PHASE2Active, not recruiting
19 participants
Started: Jun 5, 2019 · Completed: May 31, 2026
2 conditions2 sponsors1 location
NCT03766009
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
NAActive, not recruiting
627 participants
Started: Jun 5, 2019 · Completed: Dec 15, 2026
4 conditions3 sponsors58 locations
NCT04265638
Exercise Intervention in Adolescent and Young Adult Cancer Survivors
NARecruiting
66 participants
Started: Jun 5, 2019 · Completed: May 31, 2024
2 conditions1 sponsor3 locations
NCT03889795
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
PHASE1Active, not recruiting
15 participants
Started: Jun 5, 2019 · Completed: Dec 30, 2027
2 conditions1 sponsor1 location
NCT04479696
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
NARecruiting
117 participants
Started: Jun 5, 2019 · Completed: Feb 2, 2027
3 conditions2 sponsors1 location
NCT03719131
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy
PHASE2Active, not recruiting
15 participants
Started: Jun 5, 2019 · Completed: Jun 30, 2026
8 conditions2 sponsors1 location
NCT03612232
Cabozantinib in Advanced Adrenocortical Carcinoma
PHASE2Active, not recruiting
37 participants
Started: Jun 4, 2019 · Completed: Apr 30, 2025
1 condition1 sponsor2 locations
NCT04928664
Continuous vs Liposomal Bupivacaine Interscalene Block for Proximal Humeral Fracture (CLIP)
PHASE4Recruiting
78 participants
Started: Jun 4, 2019 · Completed: Aug 1, 2024
1 condition1 sponsor2 locations
NCT03969004
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
PHASE3Active, not recruiting
415 participants
Started: Jun 4, 2019 · Completed: Mar 26, 2028
1 condition1 sponsor166 locations
NCT05362721
PV Loop & Coarctation Study
N/ARecruiting
20 participants
Started: Jun 4, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor7 locations
NCT05589402
Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI
PHASE1Recruiting
30 participants
Started: Jun 4, 2019 · Completed: Jun 4, 2026
3 conditions1 sponsor1 location
NCT04446442
Cerebellar tDCS in Children With Autism Spectrum Disorder
NARecruiting
60 participants
Started: Jun 4, 2019 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT03727880
Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma
PHASE2Active, not recruiting
36 participants
Started: Jun 4, 2019 · Completed: Jan 15, 2026
2 conditions3 sponsors3 locations
NCT03915951
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
PHASE2Active, not recruiting
98 participants
Started: Jun 4, 2019 · Completed: Oct 30, 2025
1 condition1 sponsor159 locations
NCT03964311
Risk for Short-term Adverse Events in Older Emergency Department Users
NAActive, not recruiting
5,000 participants
Started: Jun 4, 2019 · Completed: Jan 1, 2025
4 conditions1 sponsor1 location